This federal Project Grant award of $997,821.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the general public. The primary awardee, Trustees of Dartmouth College, will conduct research to investigate the pathogenic role of neutrophil subpopulations in lupus nephritis. The project includes sub-awards to The...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $999,972.00 to The Feinstein Institutes for Medical Research to study urine macrophages in lupus nephritis. The research aims to shed light on kidney disease processes, with a focus on understanding complex medical conditions and developing innovative therapeutic approaches that can transform healthcare outcomes for military service...
The Defense Health Agency awarded a $754,445 Project Grant to Jackson Laboratory, a nonprofit biomedical research organization, under the Military Medical Research and Development program (CFDA 12.420). The three-year award, effective August 15, 2023 through August 14, 2026, is funding research to target the cGAS-STING axis in order to limit inflammation and neuropathology associated with Gulf War Illness. Jackson Laboratory, located in Bar Harbor, Maine, has extensive experience conducting...
This $299,998 Project Grant award was provided by the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the University of Nebraska Medical Center (UNMC). The award will support a 2-year research project from July 2024 to July 2026 entitled "VAP-1 AND METHYLGLYOXAL AS NOVEL TARGETS IN LUPUS NEPHRITIS". Through this funding, UNMC will conduct innovative biomedical research to investigate new treatment approaches for lupus nephritis, a...
This $449,000 Project Grant was awarded on September 30, 2024 by the Department of Health and Human Services (CFDA 93.493 - Congressional Directives) to Jackson Laboratory, a non-profit biomedical research institution located in Bar Harbor, Maine. The grant supports the construction or renovation of healthcare facilities, as part of congressionally directed community projects focused on addressing the healthcare needs of underserved populations. Jackson Laboratory has a robust portfolio of...
The Project Grant award of $1,000,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award will support research conducted by The Feinstein Institutes for Medical Research, a leading non-profit medical research organization, to investigate the neural substrates of fatigue and impaired cognition in individuals with lupus, a condition also known as "lupus brain fog." The research aims to advance...
The University of Houston was awarded a $750,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into interleukin-15 (IL-15) in lupus from September 30, 2021 through September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative...
The U.S. Department of Defense's Defense Health Agency awarded a $749,999 Project Grant to the University of Louisville's Office of Research & Innovation to support the "RESTORATION OF MACROPHAGE FUNCTION AS A STRATEGY TO PREVENT/TREAT LUPUS" research project. The grant, which runs from September 1, 2023 to August 31, 2026, is funded through the Military Medical Research and Development program (CFDA 12.420). This program supports a range of biomedical research aimed at...
Yale University received a $1,618,571 project grant award from the Defense Health Agency through the Military Medical Research and Development federal grant program (CFDA 12.420). The award will fund research from June 2023 through May 2027 to investigate the role of immune cell-podocyte crosstalk in the pathogenesis of APOL1-FSGS and proteinuric kidney disease. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
The U.S. Department of Health and Human Services awarded a $32,000,000 Project Grant under the Congressional Directives program (CFDA 93.493) to the Jackson Laboratory in Bar Harbor, Maine. The grant supports the construction of healthcare facilities and the purchase of medical equipment to address critical healthcare needs in underserved communities. The Jackson Laboratory, a non-profit biomedical research institution, will leverage its expertise in mammalian genetics and genomics to support...